62135-58-4 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl [1,2,4]triazolo[1,5-a]pyridine-2-carboxylate is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and properties make it an essential building block for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, Ethyl [1,2,4]triazolo[1,5-a]pyridine-2-carboxylate is utilized as an intermediate in the production of agrochemicals. Its chemical properties contribute to the creation of effective compounds for agricultural use, such as pesticides and herbicides.
Used in Anti-Cancer Research:
Ethyl [1,2,4]triazolo[1,5-a]pyridine-2-carboxylate is studied for its potential as an anti-cancer agent. Its biological activities are being investigated for its ability to target and inhibit the growth of cancer cells, offering a promising avenue for the development of novel cancer treatments.
Used in Neurological Disorder Treatment:
Ethyl [1,2,4]triazolo[1,5-a]pyridine-2-carboxylate is also being explored for its potential role in the treatment of neurological disorders. Its unique properties may contribute to the development of therapeutic agents that can address various neurological conditions, providing new treatment options for patients.
Check Digit Verification of cas no
The CAS Registry Mumber 62135-58-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,1,3 and 5 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 62135-58:
(7*6)+(6*2)+(5*1)+(4*3)+(3*5)+(2*5)+(1*8)=104
104 % 10 = 4
So 62135-58-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H9N3O2/c1-2-14-9(13)8-10-7-5-3-4-6-12(7)11-8/h3-6H,2H2,1H3
62135-58-4Relevant academic research and scientific papers
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
-
, (2019/09/30)
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
3,4-DISUBSTITUTED 1 H-PYRAZOLE AND 4,5-DISUBSTITUTED THIAZOLE INHIBITORS OF SYK
-
Page/Page column 39, (2014/05/24)
The present invention relates to the use of novel compounds of formula (I), wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
PDE10 MODULATORS
-
Paragraph 0515-0516, (2013/03/26)
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R5, W, X, X1, Y, Y1, Z and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used in the treatment of CNS disorders such as schizophrenia, Alzheimer's disease, and Parkinson's disease.
PDE10 MODULATORS
-
Page/Page column 88, (2013/03/26)
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R5, W, X, X1, Y, Y1, Z and Z1 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit PDE10A and can be used as medicaments.
ETHYL CARBOETHOXYFORMIMIDATE IN HETEROCYCLIC CHEMISTRY
Gomez, E.,Avendano, C.,McKillop, A.
, p. 2625 - 2634 (2007/10/02)
The reactions of ethyl carboethoxyformimidate with various bidentate reagents illustrate its usefulness as a reagent in heterocyclic chemistry.
